Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib and Imatinib in Metastatic or Unresectable GIST
NCT02268435Phase 1Withdrawn
- Sponsor
- Asan Medical Center
- Start
- Mar 2015
- Primary completion
- Aug 2016
01
Overview
Phase 1, open-label trial of dovitinib in gastrointestinal stromal tumor (GIST), sponsored by Asan Medical Center. Planned start Mar 2015; status: withdrawn.
02
Drugs
dovitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT02268435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268435.